An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection.

Archive ouverte

Mukherji, Atish | Juehling, Frank | Simanjuntak, Yogy | Crouchet, Emilie | del Zompo, Fabio | Teraoka, Yuji | Haller, Alexandre | Baltzinger, Philippe | Paritala, Soumith | Rasha, Fahmida | Fujiwara, Naoto | Gadenne, Cloé | Slovic, Nevena | Oudot, Marine | Durand, Sarah C. | Ponsolles, Clara | Schuster, Catherine | Zhuang, Xiaodong | Holmes, Jacinta | Yeh, Ming-Lun | Abe-Chayama, Hiromi | Heikenwälder, Mathias | Sangiovanni, Angelo | Iavarone, Massimo | Colombo, Massimo | Foung, Steven K H | Mckeating, Jane A | Davidson, Irwin | Yu, Ming-Lung | Chung, Raymond T | Hoshida, Yujin | Chayama, Kazuaki | Lupberger, Joachim | Baumert, Thomas F.

Edité par CCSD ; Nature Publishing Group -

Chronic liver disease and cancer are global health challenges. The role of the circadian clock as a regulator of liver physiology and disease is well established in rodents, however, the identity and epigenetic regulation of rhythmically expressed genes in human disease is less well studied. Here we unravel the rhythmic transcriptome and epigenome of human hepatocytes using male human liver chimeric mice. We identify a large number of rhythmically expressed protein coding genes in human hepatocytes of male chimeric mice, which includes key transcription factors, chromatin modifiers, and critical enzymes. We show that hepatitis C virus (HCV) infection, a major cause of liver disease and cancer, perturbs the transcriptome by altering the rhythmicity of the expression of more than 1000 genes, and affects the epigenome, leading to an activation of critical pathways mediating metabolic alterations, fibrosis, and cancer. HCV-perturbed rhythmic pathways remain dysregulated in patients with advanced liver disease. Collectively, these data support a role for virus-induced perturbation of the hepatic rhythmic transcriptome and pathways in cancer development and may provide opportunities for cancer prevention and biomarkers to predict HCC risk.

Suggestions

Du même auteur

Targeting the liver clock improves fibrosis by restoring TGF-β signaling.

Archive ouverte | Crouchet, Emilie | CCSD

Liver fibrosis is the major driver for hepatocellular carcinoma and liver disease related death. Approved anti-fibrotic therapies are absent and compounds in development have limited efficacy. Increased TGF-β signaling drives coll...

A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity

Archive ouverte | Roehlen, Natascha | CCSD

Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation

Archive ouverte | Crouchet, Emilie | CCSD

Hepatocellular carcinoma (HCC) is a leading cause of death among cirrhotic patients, for which chemopreventive strategies are lacking. Recently, we developed a simple human cell-based system modeling a clinical prognostic liver si...

Chargement des enrichissements...